These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
324 related articles for article (PubMed ID: 3162758)
21. Mechanisms of resistance of human small cell lung cancer lines selected in VP-16 and cisplatin. Jain N; Lam YM; Pym J; Campling BG Cancer; 1996 May; 77(9):1797-808. PubMed ID: 8646677 [TBL] [Abstract][Full Text] [Related]
22. Effect of duration of exposure to verapamil on vincristine activity against multidrug-resistant human leukemic cell lines. Cass CE; Janowska-Wieczorek A; Lynch MA; Sheinin H; Hindenburg AA; Beck WT Cancer Res; 1989 Nov; 49(21):5798-804. PubMed ID: 2790792 [TBL] [Abstract][Full Text] [Related]
23. Cellular pharmacology of Vinca alkaloid resistance and its circumvention. Beck WT Adv Enzyme Regul; 1984; 22():207-27. PubMed ID: 6089511 [TBL] [Abstract][Full Text] [Related]
24. Genetic characterization of the multidrug-resistant phenotype of VM-26-resistant human leukemic cells. Wolverton JS; Danks MK; Schmidt CA; Beck WT Cancer Res; 1989 May; 49(9):2422-6. PubMed ID: 2539902 [TBL] [Abstract][Full Text] [Related]
25. Study of sodium orthovanadate as a reverser of multidrug resistance on lymphoblastic leukemic CEM/VLB100 cells. Colin M; Madoulet C; Baccard N; Arsac F; Jardillier JC Anticancer Res; 1994; 14(6A):2383-7. PubMed ID: 7825977 [TBL] [Abstract][Full Text] [Related]
26. [Cross and non-cross resistant anticancer agents to multidrug-resistant cultured cells from hematologic malignancies]. Shimoyama M; Ishida Y; Ohtsu T; Shimada Y; Tobinai K; Minato K Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):1273-9. PubMed ID: 2730025 [TBL] [Abstract][Full Text] [Related]
27. Modulation of drug cytotoxicity in wild-type and multidrug-resistant tumor cells by stereoisomeric series of C-20'-vinblastine congeners that lack antimicrotubule activity. Borman LS; Bornmann WG; Kuehne ME Cancer Chemother Pharmacol; 1993; 31(5):343-9. PubMed ID: 8431967 [TBL] [Abstract][Full Text] [Related]
28. Multiple microtubule alterations are associated with Vinca alkaloid resistance in human leukemia cells. Kavallaris M; Tait AS; Walsh BJ; He L; Horwitz SB; Norris MD; Haber M Cancer Res; 2001 Aug; 61(15):5803-9. PubMed ID: 11479219 [TBL] [Abstract][Full Text] [Related]
29. Modulation of vindesine and doxorubicin resistance in multidrug-resistant pleural mesothelioma cells by tumor necrosis factor-alpha. Licht T; Lübbert M; Martens C; Bross KJ; Fiebig HH; Mertelsmann R; Herrmann F Cytokines Mol Ther; 1995 Jun; 1(2):123-32. PubMed ID: 9384669 [TBL] [Abstract][Full Text] [Related]
30. Essential features of the P-glycoprotein pharmacophore as defined by a series of reserpine analogs that modulate multidrug resistance. Pearce HL; Safa AR; Bach NJ; Winter MA; Cirtain MC; Beck WT Proc Natl Acad Sci U S A; 1989 Jul; 86(13):5128-32. PubMed ID: 2567994 [TBL] [Abstract][Full Text] [Related]
31. Mechanism of resistance to anthracyclines and vinca alkaloids. Danø K; Skovsgaard T; Nissen NI; Friche E; Di Marco A Prog Clin Biol Res; 1983; 132C():231-46. PubMed ID: 6579564 [TBL] [Abstract][Full Text] [Related]
32. Synthesis and chemical characterization of N-substituted phenoxazines directed toward reversing vinca alkaloid resistance in multidrug-resistant cancer cells. Thimmaiah KN; Horton JK; Seshadri R; Israel M; Houghton JA; Harwood FC; Houghton PJ J Med Chem; 1992 Sep; 35(18):3358-64. PubMed ID: 1527786 [TBL] [Abstract][Full Text] [Related]
33. Modulation of etoposide (VP-16) cytotoxicity by verapamil or cyclosporine in multidrug-resistant human leukemic cell lines and normal bone marrow. Chao NJ; Aihara M; Blume KG; Sikic BI Exp Hematol; 1990 Dec; 18(11):1193-8. PubMed ID: 2226679 [TBL] [Abstract][Full Text] [Related]
34. Physicochemical properties correlated with drug resistance and the reversal of drug resistance in Plasmodium falciparum. Bray PG; Hawley SR; Mungthin M; Ward SA Mol Pharmacol; 1996 Dec; 50(6):1559-66. PubMed ID: 8967978 [TBL] [Abstract][Full Text] [Related]
35. Evidence for transcriptional control of human mdr1 gene expression by verapamil in multidrug-resistant leukemic cells. Muller C; Goubin F; Ferrandis E; Cornil-Scharwtz I; Bailly JD; Bordier C; Bénard J; Sikic BI; Laurent G Mol Pharmacol; 1995 Jan; 47(1):51-6. PubMed ID: 7838133 [TBL] [Abstract][Full Text] [Related]
36. The effect of lysosomotropic agents and secretory inhibitors on anthracycline retention and activity in multiple drug-resistant cells. Klohs WD; Steinkampf RW Mol Pharmacol; 1988 Aug; 34(2):180-5. PubMed ID: 2901030 [TBL] [Abstract][Full Text] [Related]
37. Current developments in antitumor antibiotics, epipodophyllotoxins, and vinca alkaloids. Rowinsky EK Curr Opin Oncol; 1991 Dec; 3(6):1060-9. PubMed ID: 1843108 [TBL] [Abstract][Full Text] [Related]
38. Structure-activity studies of amsacrine analogs in drug resistant human leukemia cell lines expressing either altered DNA topoisomerase II or P-glycoprotein. Granzen B; Graves DE; Baguley BC; Danks MK; Beck WT Oncol Res; 1992; 4(11-12):489-96. PubMed ID: 1363724 [TBL] [Abstract][Full Text] [Related]
39. Theoretical insight into the structural mechanism for the binding of vinblastine with tubulin. Chi S; Xie W; Zhang J; Xu S J Biomol Struct Dyn; 2015; 33(10):2234-54. PubMed ID: 25588192 [TBL] [Abstract][Full Text] [Related]
40. Modulation of P-glycoprotein-mediated multidrug resistance in K562 leukemic cells by indole-3-carbinol. Arora A; Seth K; Kalra N; Shukla Y Toxicol Appl Pharmacol; 2005 Feb; 202(3):237-43. PubMed ID: 15667829 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]